Showing 16,161 - 16,180 results of 32,731 for search '(( 50 ((((mean decrease) OR (we decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 1.01s Refine Results
  1. 16161

    Sexual differences in daily foraging patterns among Great tits <i>Parus major</i> established by radio frequency identification (RFID) tags by Joachim Siekiera (7478408)

    Published 2019
    “…In contrast, during early spring we found a significant bimodal pattern only for females with a sharp decrease before dusk. …”
  2. 16162

    Data_Sheet_1_The optimal pulse pressures for healthy adults with different ages and sexes correlate with cardiovascular health metrics.doc by Chung-Hsing Chou (626009)

    Published 2022
    “…In a prospective cohort, we studied subjects with favorable cardiovascular health (CVH), proposed the mean PP as the optimal PP values, and demonstrated its relationship with healthy lifestyles.…”
  3. 16163
  4. 16164

    Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using “Neo-Islets,” aggregates of adipose stem and pancreatic islet cells... by Anna Gooch (7406363)

    Published 2019
    “…Current results from this translational study indicate that in dogs, Neo-Islets appear to engraft, redifferentiate and physiologically produce insulin, and are rejected by neither auto- nor allo-immune responses, as evidenced by (a) an absent IgG response to the allogeneic cells contained in the administered Neo-Islets, and (b) progressively improved glycemic control that achieves up to a 50% reduction in daily insulin needs paralleled by a statistically significant decrease in serum glucose concentrations. …”
  5. 16165

    Effects of Analgesic Doses of Opioids on Cardiorespiratory Responses and Survival to Hemorrhage and Trauma in Rats Supplemental Table by Stephanie Lipiec (20720822)

    Published 2025
    “…<p dir="ltr">Opioids are used for analgesia but questions persist about their safety following traumatic hemorrhage. We investigated <i>analgesic</i> doses of three opioids (morphine, fentanyl and sufentanil) on cardiorespiratory responses and survival to moderate or severe (37 and 50% blood volume) hemorrhage after trauma. …”
  6. 16166

    Andro induced ROS-dependent autophagy while Taxi attenuated it. by Mazen Alzaharna (3737878)

    Published 2017
    “…<p>Cells were treated as indicated, stained with DCF-DA and then analyzed using the flow cytometer. (A) A representative histograms showing the increase in ROS in HeLa cells treated with Andro (25, 50 or 100 μM) while the decrease in ROS in those treated with Taxi (50, 100 or 200μM) for 24h. …”
  7. 16167
  8. 16168

    Contribution of anti-MPER antibodies to the plasma's cross-neutralizing activities. by Iliyana Mikell (120166)

    Published 2011
    “…The Log10 decrease in IC50 neutralization titers in the presence of the MPER peptide is indicated.…”
  9. 16169
  10. 16170

    TGF-β1-induced suppression of COX-2 expression by transcriptional repression. by Erina Takai (465811)

    Published 2013
    “…<p>(A) Time-dependent decrease of COX-2 mRNA expression by treatment with TGF-β1 (5 ng/mL). …”
  11. 16171

    Data_Sheet_1_Effect of epidural spinal cord stimulation on female sexual function after spinal cord injury.docx by Claire Shackleton (13369920)

    Published 2023
    “…Sexual distress was reduced by 55%, with a mean decrease of 12 points (55.4%) from baseline (21.7 ± 17.2) to post-intervention (9.7 ± 10.8). …”
  12. 16172

    Increased Autophagy in <i>daf-2/</i>insulin/IGF Receptor Mutants Is Independent of the <i>daf-16</i>/FOXO and <i>pha-4</i>/FOXA Transcription Factors by Malene Hansen (10367)

    Published 2008
    “…The mean lifespan of <i>daf-2(e1370)</i> animals was shortened 12.5% by <i>pha-4</i> RNAi ([<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.0040024#pgen-0040024-b028" target="_blank">28</a>] and data not shown), and we measured an 11% decrease in puncta in <i>daf-2(e1370)</i> animals fed <i>pha-4</i> RNAi. …”
  13. 16173

    SOX4 trans-activates the transcription of <i>SEMA3</i>, <i>Plexin</i>, and <i>NRP1</i>. by Hsin-Yi Huang (111181)

    Published 2012
    “…<p>(A) representative end-point PCR of chromatin immunoprecipitation (ChIP) using an antibody against SOX4 in PANC-1 cells. …”
  14. 16174

    Mapping of serum neutralizing activity in high titer, protected RM using BG505 Env PV mutants. by Tysheena P. Charles (3385586)

    Published 2021
    “…<p>Serum neutralizing activity on the day of challenge (week 84) was evaluated using the TZM-bl assay (<b>AE</b>) and ID<sub>50</sub> titers were calculated using GraphPad prism. …”
  15. 16175
  16. 16176
  17. 16177

    Kinetic characterization of GK and its inhibition by GKRP. by Magdiel Salgado (553127)

    Published 2014
    “…<p><b>A</b>, Using a glucose-6-phosphate dehydrogenase-coupled method, we evaluated the concentration dependence of glucose phosphorylation by recombinant GK with 1 mM ATP and pH 7.5. …”
  18. 16178

    NAA concentrations versus post-conceptional age. by Stefan Blüml (382480)

    Published 2014
    “…When NAA concentrations of premature infants are plotted (<b>B</b>), a discrepancy is readily noticed for parietal WM (note that the fitted curve for term infants was carried over from figure <b>A</b> and that there are more points above than below that curve) but is not observed for parieto/occipital GM and is also less apparent for frontal WM where fewer data points are available. …”
  19. 16179

    Split luciferase assay-based screen identifies new phospho-regulatory pathways upstream of the FGF14:Nav1.6 channel complex. by Wei-Chun Hsu (689900)

    Published 2015
    “…<b>(C)</b> Example time series data for increased (triciribine), unchanged (ML-7 Hydrochloride) or decreased (Wee1 inhibitor) luminescence relative to control (Cluc-FGF14 / CD4-Nav1.6-Nluc) shown, at a final concentration of 50 μM. …”
  20. 16180

    Loss of MYRF leads to early retinal degeneration in mice. by Sarah J. Garnai (6658520)

    Published 2019
    “…<p>(A-C) H&E histology of P3 (A), P14 (B), and P22 (C) control (<i>Myrf</i><sup>+/fl</sup> or <i>Myrf</i><sup><i>fl/fl</i></sup>) or <i>Myrf</i> heterozygous and homozygous conditional knockout mice (<i>RxCre;Myrf</i><sup><i>+/fl</i></sup> and <i>RxCre;Myrf</i><sup><i>fl/fl</i></sup>). …”